Ablexis Forms Five-Member Pharmaceutical Consortium to Fund Technology Development.

Extract


Ablexis Forms Five-Member Pharmaceutical Consortium to Fund Technology Development.

Non-Exclusive Partnership Validates Potential of Technology and Provides Access to Novel Transgenic Mouse Platform for the Discovery of Antibody Therapeut...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company